Which federal agency does American Academy of Pediatrics (AAP) comment on most?

American Academy of Pediatrics (AAP) is most active at the Food and Drug Administration.

← OpenPolis Sign in

American Academy of Pediatrics (AAP)

Unclaimed

Industry

Nonprofit management

Staff

1,200

345 Park Blvd, Itasca, IL 60143

Phone

+1 847-434-4000

Website

aap.org

Engagement overview

American Academy of Pediatrics (AAP) has filed 483 public comments across 363 dockets at 25 federal agencies, most actively at the Food and Drug Administration.

American Academy of Pediatrics (AAP)

Engagement overview

Is this your organization?

Agency footprint

Dockets (363)

Rescission of Regulatory Determinations and Removal of Related Provisions for Four PFAS Substances (PFHxS, PFNA, HFPO-DA (GenX), and the mixture of these three PFAS plus PFBS)

Advancing the Use of Digital Health Technologies in Clinical Investigations for Drugs and Biological Products; Request for Information and Comments

AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program; Request for Information

FR-6524-P-01 Housing and Community Development Act of 1980: Verification of Eligible Status

Untitled docket

Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products; Draft Guidance for Industry; Availability

Meeting of the Advisory Committee on Immunization Practices 3/18-3/19

Modified Risk Tobacco Product Application: Applications for ZYN products Submitted by Swedish Match U.S.A. Inc.

Review of Science on Fluoride in Drinking Water

Health Data, Technology, and Interoperability: ASTP/ONC Deregulatory Actions To Unleash Prosperity

Perchlorate National Primary Drinking Water Regulation

Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use

Pregnancy Risk Assessment Monitoring System (PRAMS)

NPRM COMMENTS CLOSE ON 12/19/25; PRA COMMENTS CLOSE ON 1/20/26; Public Charge Ground of Inadmissibility

Meeting of the Advisory Committee on Immunization Practices - December 2025

Over-the-Counter Monograph Procedure for Minor Changes C001: Minor Changes to Solid Oral Dosage Forms for Certain Over-the-Counter Monograph Drugs

Interested Parties Meeting: Implementation of the Best Pharmaceuticals for Children Act and Pediatric Research Equity Act

Food Safety and Inspection Service Ultra-Processed Foods; Request for Information

Establishing a Fixed Time Period of Admission and an Extension of Stay Procedure for Nonimmigrant Academic Students, Exchange Visitors, and Representatives of Foreign Information Media

Meeting of the Advisory Committee on Immunization Practices - September 2025

Infant Formula Nutrient Requirements; Request for Information

Reauthorization of the Medical Device User Fee Amendments; Public Meeting; Request for Comments

Food Labeling: Front-of-Package Nutrition Information

Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in the Pediatric Population; Public Meeting; Establishment of a Public Docket; Request for Comments

Over-the-Counter Monograph Condition B001: Single-Unit or Unit-Dose Containers for Over-the-Counter Monograph Drugs in Orally Disintegrating Tablet and Film Dosage Forms

ACIP - Committee Meeting (June 25-26, 2025)

Petition Requesting a Mandatory Regulation for Child-Resistant Above-Ground and Portable Pool Ladders; Request for Comments

Alien Registration Form and Evidence of Registration

April 15-16, 2025, Meeting of the Advisory Committee on Immunization Practices

Proposed Modifications to the HIPAA Security Rule to Strengthen the Cybersecurity of ePHI

Request for Public Comments on the Scientific Report of the 2025 Dietary Guidelines Advisory Committee

Chlorpyrifos Tolerance Rule

Notifying FDA of a Permanent Discontinuance in the Manufacture or an Interruption of the Manufacture of an Infant Formula; Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request

Notice of Proposed Rulemaking: Requirements for Neck Floats

Enhancing Coverage of Preventive Services under the Affordable Care Act

Live Biotherapeutic Products to Prevent Necrotizing Enterocolitis in Very Low Birth Weight Infants; Public Workshop; Request for Comments

Safety Standard for Toys - Requirements for Water Beads

FR-6486-N-02 Modifying HUD’s Elevated Blood Lead Level Threshold for Children Under Age 6 Who Are Living in Certain HUD-Assisted Target Housing Covered by the Lead Safe Housing Rule

Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials; Draft Guidance for Industry; Availability

Health Data, Technology, and Interoperability: Patient Engagement, Information Sharing, and Public Health Interoperability

Pediatric Inflammatory Bowel Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability

Malathion Registration Review

Listening Session: Optimizing FDA’s Use of and Processes for Advisory Committees; Public Meeting; Request for Comments

Banned Devices; Proposal to Ban Electrical Stimulation Devices for Self-Injurious or Aggressive Behavior Center: Center for Devices and Radiological Health

Safety Standard for Bassinets and Cradles: Notice of Proposed Rulemaking

AFCARS 2024

Methane Emissions and Waste Reduction Incentive Program for Petroleum and Natural Gas Systems

NPR Safety Standard for Infant Support Cushions

National Primary Drinking Water Regulations: Lead and Copper Rule Improvements

Technical Guidance for Assessing Environmental Justice in Regulatory Analysis

21st Century Cures Act: Establishment of Disincentives for Health Care Providers That Have Committed Information Blocking

Notice of Proposed Rulemaking - Safety Standard for Infant Rockers and Infant and Toddler Rockers

Request for Information; Coverage of Over-the-Counter Preventive Services

Kids Online Health and Safety Task Force

Safety Standard for Nursing Pillows

Foster Care Legal Representation

Safe and Appropriate Foster Care Placement Requirements for Titles IV-E and IV-B

Requirements Related to the Mental Health Parity and Addiction Equity Act

Regulations to Implement the Pregnant Workers Fairness Act

Health and Human Services Grants Regulation

Reconsideration of the Dust-Lead Hazard Standards and Dust-Lead Post-Abatement Clearance Levels

New Source Performance Standards for GHG Emissions from New and Reconstructed EGUs; Emission Guidelines for GHG Emissions from Existing EGUs; and Repeal of the Affordable Clean Energy Rule

Guidance for industry on Pediatric Drug Development Under the Pediatric Research Equity Act and Qualifying for Pediatric Exclusivity Under the Best Pharmaceuticals for Children Act

HIPAA Privacy Rule to Support Reproductive Health Care Privacy

Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing

Petition to Establish U.S. Tolerances for Residues of Chlormequat Chloride in or on Wheat, Barley, and Oats and Secondary Residues in Meat, Milk, Poultry, and Eggs

Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development; Draft Guidance for Industry; Availability

Separate Licensing Standards for Relative or Kinship Foster Family Homes

Information Disclosure Under Section 6(b) of the Consumer Product Safety Act

Circumvention of Lawful Pathways

Reducing Greenhouse Gas Emissions from New and Existing Fossil Fuel-Fired Electric Generating Units

Action Levels for Lead in Food Intended for Babies and Young Children; Draft Guidance for Industry; Availability

Safeguarding the Rights of Conscience as Protected by Federal Statutes

Use of the Term “Healthy” in the Labeling of Human Food Products

CDC Recommendations for Hepatitis C Testing Among Perinatally Exposed Infants and Children